Welcome to our dedicated page for Nasdaq news (Ticker: NDAQ), a resource for investors and traders seeking the latest updates and insights on Nasdaq stock.
The Nasdaq, Inc. (Nasdaq: NDAQ) news page on Stock Titan aggregates official announcements, market updates, and regulatory disclosures from a global technology company that operates The Nasdaq Stock Market and related capital markets businesses. Nasdaq’s communications highlight its role in serving corporate clients, investment managers, banks, brokers, and exchange operators through data, analytics, software, exchange capabilities, and index solutions.
Visitors can review news on listings and index changes, such as annual reconstitutions of the Nasdaq-100 Index and constituent updates involving companies being added or removed. Nasdaq also issues releases about capital formation activity, including the amount of capital raised from new listings and notable exchange transfers, as well as updates from Nasdaq Global Indexes on methodology and index families across asset classes and geographies.
The feed also features corporate finance and balance sheet actions, including announcements about cash tender offers for outstanding senior notes, early tender results, and pricing details. In addition, Nasdaq publishes information about investor events, such as scheduled quarterly and full-year earnings announcements, investor conference calls, and the availability of volume statistics and presentation materials.
Because Nasdaq operates The Nasdaq Stock Market, its news includes market operations and regulatory notices like trading halts, delisting decisions, and references to listing and delisting rules. Technology and data partnerships, such as the integration of Nasdaq eVestment into third-party platforms, also appear in the company’s releases. This page helps readers follow how Nasdaq’s exchange, index, data, and technology activities evolve over time through its own public disclosures.
Summary not available.
Nasdaq (NDAQ) will announce its Fourth Quarter 2020 financial results on January 27, 2021, at 8:00 AM Eastern. The announcement will be accompanied by a conference call featuring Nasdaq's CEO, CFO, and senior management. Participants can access the call via the Nasdaq Investor Relations website. An audio replay will be available afterward. The press release will be published on the Investor Relations website earlier that day at approximately 7:00 AM Eastern. This event offers insights into Nasdaq's latest financial performance and strategic direction.
In 2020, Nasdaq (NDAQ) led the U.S. exchange market by welcoming 300 IPOs, raising a total of $77.86 billion, marking its largest IPO year in the past decade. With an 83% success rate for operating companies, Nasdaq also attracted 21 firms switching from the NYSE, representing $278 billion in market value. Significant IPOs included Airbnb and Warner Music Group. Nasdaq's initiatives to modernize SEC rules further underscore its commitment to enhancing market integrity. The exchange continues to dominate sectors like Health Care and Technology, achieving impressive win rates in venture and private equity-backed listings.
Summary not available.
Nasdaq (Nasdaq: NDAQ) will implement its annual reconstitution of the Nasdaq-100 Index® on December 21, 2020. Six companies will join the index, including American Electric Power Company, Marvell Technology Group, and Peloton Interactive. The reconstitution process involves adding and removing companies based on market capitalization, with the new additions replacing companies like BioMarin Pharmaceutical and Take-Two Interactive. The Nasdaq-100 Index serves as a benchmark for various financial products and is crucial for market performance tracking.
On December 11, 2020, Nasdaq (NDAQ) announced the reconstitution of the Nasdaq Biotechnology Index (NBI), effective December 21, 2020. This annual adjustment will include 100 new biotech and pharmaceutical securities, enhancing the index's representation in the sector. Notable additions are Arbutus Biopharma, Adaptimmune Therapeutics, and BioNTech, among others. Conversely, 16 securities will be removed from the index, including ADMA Biologics and Myris, Inc. The changes aim to better reflect market trends and advance investor insights into the biotech landscape.
Summary not available.
Nasdaq, Inc. (NDAQ) has announced a public offering totaling $1.9 billion in senior notes with varying maturity dates: $600 million at 0.445% due in 2022, $650 million at 1.650% due in 2031, and $650 million at 2.500% due in 2040. The net proceeds will finance the acquisition of Verafin, cover its outstanding debts, and support general corporate needs. The offering closes on December 21, 2020, pending customary conditions.
Nasdaq, Inc. (NDAQ) announced its plan to offer senior notes, subject to market conditions, to finance its pending acquisition of Verafin Holdings Inc. The expected net proceeds will also be used to repay Verafin's outstanding debts and for general corporate purposes. Major banks, including J.P. Morgan and Goldman Sachs, will manage the Offering. The Offering will be conducted under a previously filed shelf registration with the SEC and will include forward-looking statements about potential risks and market conditions.
Nasdaq (Nasdaq: NDAQ) reported its monthly trading volumes for November 2020, emphasizing its role in global capital markets. The detailed statistics can be accessed via their investor relations website. The company is committed to delivering data, analytics, software, and services to help clients achieve business goals. Nasdaq also included a cautionary note regarding forward-looking statements, acknowledging potential risks such as market fluctuations and regulatory actions, which may impact future performance.